Evidence map›Paper›PMID 40291904›Full record

ArticleFrontiers in oncology2025

Preoperative CT-based radiomics nomogram for progression-free survival prediction in pediatric posterior mediastinal malignancies.

Shucheng Bi, Chenghao Chen, Jie Yu, Ting Yang, Jihang Sun, Zunying Hu, Qi Zeng, Yun Peng

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shucheng Bi *Department of Radiology, Ministry of Education (MOE) Key Laboratory of Major Diseases in Children, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Chenghao Chen *Department of Thoracic Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Jie YuDepartment of Thoracic Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Ting YangDepartment of Thoracic Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Jihang SunDepartment of Radiology, Ministry of Education (MOE) Key Laboratory of Major Diseases in Children, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Zunying HuDepartment of Radiology, Ministry of Education (MOE) Key Laboratory of Major Diseases in Children, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Qi ZengDepartment of Thoracic Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Yun PengDepartment of Radiology, Ministry of Education (MOE) Key Laboratory of Major Diseases in Children, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Progression-free survival (PFS) prediction plays a pivotal role in developing personalized treatment strategies and ensuring favorable long-term outcomes in pediatric posterior mediastinal malignant tumors. This study developed and validated the first preoperative contrast-enhanced computed tomography (CT)-based radiomics nomogram to forecast PFS in posterior mediastinal malignancies patients. The aim was to provide a clinically applicable prognostic tool to stratify high-risk populations. Methods: Medical data from 306 patients with posterior mediastinal malignancies were analyzed retrospectively and randomly divided into training (n = 215) and test sets (n = 91). The clinical model was built using conventional clinical data and CT signs. Selection of the radiomic features was performed using maximum relevance minimum redundancy and the least absolute shrinkage and selection operator. To overcome class imbalance, the synthetic minority over-sampling technique was used in the training set. Radiomics signature was derived using logistic regression algorithm, and we developed a nomogram by integrating the clinical model and the radiomics signature. The predictive efficiency of the nomogram was assessed using the area under the curve (AUC), brier score (BS), decision curve analysis, and calibration. Results: The Ki-67 index and metastasis were identified as independent predictors, with the test set achieving an AUC of 0.82 (0.647-0.964) and a BS of 0.21 (0.181-0.239). Nineteen radiomics features most relevant to PFS were retained, with the logistic regression algorithm achieving an AUC of 0.77 (0.589-0.896) and a BS of 0.26 (0.215-0.292) in the test set. The radiomics nomogram demonstrated best predictive capability in the test set, achieving an AUC of 0.87 (0.733-0.968) and a BS of 0.22 (0.177-0.255), compared with remaining prediction models. Both calibration curves and decision curve analysis demonstrated good fit and clinical benefit. Conclusions: Our contrast-enhanced CT-based radiomics nomogram may be a dependable, precise, and noninvasive prognostic tool to predict PFS in pediatric posterior mediastinal malignancies preoperatively.

Indexed as

CTmalignantmediastinalpediatricprogression-free survivalradiomics

Identifiers

PMID40291904
PMCPMC12021605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.